A potential involvement of Aβ in APP dependent KCC2 regulation cannot be excluded and one could speculate that increased levels of Aβ and/or an alteration in the physiological function of APP could influence KCC2 expression in AD. The gene discussed is APP; the disease is Alzheimer disease.